65,437 trials
SARS-CoV-2 Infection · COVID-19 · Maternal Immunization
Primary: Percentage of Maternal Participants Reporting Local Reactions Within 7 Days After Dose 1 — 2.5; 0.6; 0.6; 0 Percentage of participants
Type 1 Diabetes Mellitus · Hypoglycemia · Arrythmia
Primary: Proportion of Time Spent in the Target Sensor Glucose Range During the 16 Week Intervention Period (%) — 79.9; 71.4 % of time
Metastatic Breast Cancer · Breast Carcinoma
Primary: Progression Free Survival (PFS) — 2.76; 5.29 months
Healthy
Primary: Change in Live LcS Numbers From Baseline (Day 14) to the End of the Ingestion Period (Day 28). — 2.14; 5.27 Log 10 CFU/g Feces
Arthritis, Degenerative
Primary: Number of Participants With Device-Related Revisions — 1; 0; 19; 6 Participants
Respiratory Syncytial Virus Infections · Influenza, Human
Primary: Total Symptom Score — 29.25; 17.50; 11.00; 13.00 score on a scale
Atopic Dermatitis
Primary: Change in Area Under the Concentration-time Curve From Time Zero to Infinity (AUC[0-infinity]) of Each of the 5 Probe Drugs Before and After 9-week Nemolizumab Treatment…
Pneumococcal Carriage
Primary: Effect of a Single Dose PCV10 Campaign in the Reduction of VT Carriage — 4.6; 8.0; 16.5 Percentage of participants
Schizophrenia · Schizoaffective Disorder · Bipolar Disorder
Primary: Nocturnal Melatonin Production — 11.19; 19.09; 10.39; 15.18 mg/dL
Parkinson Disease · Orthostatic Hypotension
Primary: Change in Systolic Blood Pressure From Supine to Tilt at 3 Minutes — -24.22; -20.32 mmHg
Disaster · Vulnerable Populations
Primary: Household Emergency Preparedness Instrument (HEPI) Score — 5.5; 20.2 score on a scale
Depression · Major Depressive Disorder · Depressive Disorder
Primary: Resting State Functional Connectivity: MDD vs Controls — .51; .65; .54 Z normalized correlation
Hypertension · Pulmonary Arterial Hypertension · Familial Primary Pulmonary Hypertension
Primary: Transthoracic Echocardiogram (ECHO)-Based Change in the Tricuspid Annular Plane Systolic Excursion (TAPSE) Measurement — 2.244; 2.244; 2.300; 2.212 mm
Hip Injuries · Pain · Therapy/Rehabilitation
Primary: Global Rating of Change — 7; 3; 16; 21 Participants — p=0.879
Trichuriasis · Ascariasis · Hookworm Infections
Primary: Egg Reduction Rate Against T. Trichiura — 96.8; 99.0; 86.2; 94.2 Percent change